ÃâÒßѧÊÔÌâ
EPS={w$'s Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
7G.#O}).b 1. Fas(CD95)/FasL
n,=VQOu 2. common chain of cytokine receptor
=g/{%; 3 . TCR/CD3 complex
7w
37S 4. negaive selection of thymocytes
GN-mrQo 5. artificial active immune
$wmvKQc{lx 6. anti-idiotypic
dlJbI}-v= 7. IgSF
,stN 8. Integrin
+
`
s@ 9. chemokine
V2$h8\a 10. B7/CD28
T?:glp[4I ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
{LX.iH
9}l 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
]?3un!o3o 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
Gqcq,_?gt 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
t'BLVCu 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
t<~ $
Vl_:c75" 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
jov:]Bic µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
S
|apw7C Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
N-
I5X2 1. B7/CD28
bhkUKxd 2. Th1 subset
vw>2(K=e1 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
w=j 4. antibody affinity maturation
1QmH{jM 5. AP-1
0G7K8`a 6. single chain variable fragment£¨ScFv£©
"*LD 3 7. NK cell receptor
emK$`9 8. Zinkernagel-Doherty phenomenon
yHHt(GM|o 9. Ig fold
#ggf' QIHp 10. CD40/CD40L
(q{Ck#+ ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
Z9575CI< 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
e*bH0'; q 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
jy giG&H 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
z "+Mrew Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
Ps%qfL\ 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
EI_ 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
TjQvAkT 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
OiE;B Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
K'X
2dG* £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
ZO4*sIw%
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
C?i >.t 1.Co-stimulators (or co-stimulating molecules)
:um|nRwy9 2.NK-kB
|1ST=O7.LH 3.Immunoglobulin superfamily
U$
F{nZ1 4.antigen-presenting cell (APC)
q EP
4 5.death domain
=JKv:</.G 6.CCR and CXCR
O~59FuL 7.Lectin (or mitogen)
&g.@u~SI1 8.Clusters of differentiation, CD)
2Fz|fW_ 9.B7 family
G7)Fk%> 10.Cytotoxic T lymphocyte, CTL)
-T&.kYqnb$ 11.IL-15 and IL-15 receptor (IL-15R)
-S$1Yn 12.MHC restriction
mcn 2Wt 13.Affinity-chromatography
LwhyE:1 14.Cyctosprin A, CsA
$Bj;D=d@V 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
^=:9)CNw( ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
BWrv%7 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
K"b`#xN(t 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
;b`[&g 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
zH>hx5,k'X Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
549jWG ÃâÒßѧרҵ£º
@FC"nM
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
FJ % Ïû»¯ÄÚ¿Æ£º
cwm_nQKk 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
cZ(elZ0~ ѪҺ²¡Ñ§×¨Òµ£º
zOV=9"~{ 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
"dROb}szn Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
P ~#>H{ (רҵ»ù´¡: ÃâÒßѧ)
f+|$&p% Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
h.!}3\Y 1. ADCC(antibody dependent cell-mediated cytotoxicity)
A<6%r7&B' 2. »·æß¾úËØ(cyclosporin)
t=*@yQ
nB 3. KIR(killer cell inhibitory receptor)
e#,~,W.H 4. HLDA(human leucocyte differentiation antigen)
<H0R&l\ 5. Interleukin 18(IL-18)
#-8\JEn 6. ÕûºÏËØ(integrin)
n!')wIk 7. Fas/FasL
<,AS8^$X[ 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
FSRm| 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
? tfT8$ 10. Th1/Th2
uZZU{U9h 11. »ùÒòÒßÃç(DNAÒßÃç)
\`ZW* EtPI 12. chemokines and chemokine receptor
RZe'Kw - 13. ÃâÒßÄÍÊÜ
Yk42(!
14. ¹²´Ì¼¤·Ö×Ó
]`b
QW? 15. ËÀÍö½á¹¹Óò(death domain)
Hg9CZMko ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
-!0_:m3 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
W5^.-B,(K 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
5@hNnh16 £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
+
dBz`WD £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
RUr=fEH £¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
6l$L~> £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
Dfd-^
N!
3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
|v[ Rp
=?] Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
aF|d^ ÎÊ´ðÌâ(ÿÌâ25·Ö)
K^rIG6 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
*WE1;msr 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
l{VSb92f 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
"lNzGi-H 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£